<DOC>
	<DOCNO>NCT02635373</DOCNO>
	<brief_summary>Observational , registry , prospective , non-interventional collection CUA patient data . Patient treatment carry within clinical routine , discretion physician accord exist treatment guideline . Participating physician subject instruction regard diagnosis therapy patient .</brief_summary>
	<brief_title>European Calciphylaxis Registry Network</brief_title>
	<detailed_description>Calcific uremic arteriolopathy ( CUA , calciphylaxis ) rare disease ( ORPHA280062 ) dramatically high mortality characterize clinically occurrence painful debilitate cutaneous lesion ulceration . Median survival time 1.5 year . Many uncertainty still exist risk factor optimal therapy . CUA mainly occur patient severe renal insufficiency ESRD . The aim present initiative establish international ( European ) observational registry CUA patient . This registry help reach critical mass CUA patient , allow novel insight pathophysiology , help establish systematically overview upon risk factor long-term outcome CUA patient . The design international registry suppose adopt structure presently run nation-wide German calciphylaxis registry . The investigator plan initiate registry treat physician provide data upon demographic , clinical picture , comorbidities , medical treatment laboratory data time diagnosis serial follow-up time point . In addition investigator build-up biobank full blood , serum plasma sample well tissue sample . The registry allow investigation regard potential subgroup patient ( proximal versus distal form CUA ) , geno-phenotype correlation , description international state-of-the-art treatment , identification preventive tool , risk factor biomarkers estimation prognosis . Furthermore , registry nidus scientific exchange expert clinician field uremic vascular calcification .</detailed_description>
	<mesh_term>Calciphylaxis</mesh_term>
	<criteria>diagnose CUA accord judgement locally treat physician , option ask external diagnostic advice countryspecific subinvestigators Male female age &gt; 18 year Written inform consent prior study participation The subject mentally legally incapacitate â€¢ The subject able give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Calciphylaxis</keyword>
	<keyword>Rare disease ( ORPHA280062 )</keyword>
	<keyword>Renal insufficiency</keyword>
	<keyword>ESRD</keyword>
	<keyword>Calcification</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Vascular disease</keyword>
</DOC>